Phase I clinical study of the recombinant antibody toxin...

Breast Cancer Research 2005 / 10 Vol. 7; Iss. 5

Phase I clinical study of the recombinant antibody toxin scFv(FRP5)-ETA specific for the ErbB2/HER2 receptor in patients with advanced solid malignomas

Gunter von Minckwitz, Sebastian Harder, Sascha Hövelmann…
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
7
Language:
english
DOI:
10.1186/bcr1264
Date:
October, 2005
File:
PDF, 326 KB
english, 2005
Conversion to is in progress
Conversion to is failed